HuyettLM, LyTT, ForlenzaGP, et al.Outpatient closed-loop control with unannounced moderate exercise in adolescents using zone model predictive control. Diabetes Technol Ther, 2017; 19: 331–339.
2.
DassauE, RenardE, PlaceJ, et al.Intraperitoneal insulin delivery provides superior glycemic regulation to subcutaneous insulin delivery in model predictive control-based fully-automated artificial pancreas in patients with type 1 diabetes: a pilot study. Diabetes Obes Metab, 2017; 19: 1698–1705.
3.
KitagawaH, YatabeT, NamikawaT, MunekageM, HanazakiK. Postoperative closed-loop glycemic control using an artificial pancreas in patients after esophagectomy. Anticancer Res, 2016; 36: 4063–4067.
4.
MitaN, KawahitoS, SogaT, et al.Strict blood glucose control by an artificial endocrine pancreas during hepatectomy may prevent postoperative acute kidney injury. J Artif Organs, 2017; 20: 76–83.
5.
NamikawaT, MunekageM, KitagawaH, et al.Comparison between a novel and conventional artificial pancreas for perioperative glycemic control using a closed-loop system. J Artif Organs, 2017; 20: 84–90.
6.
FarringtonC, StewartZA, BarnardK, HovorkaR, MurphyHR. Experiences of closed-loop insulin delivery among pregnant women with Type 1 diabetes. Diabet Med, 2017; 34: 1461–1469.
7.
SharifiA, De BockMI, JayawardeneD, et al.Glycemia, treatment satisfaction, cognition, and sleep quality in adults and adolescents with type 1 diabetes when using a closed-loop system overnight versus sensor-augmented pump with low-glucose suspend function: a randomized crossover study. Diabetes Technol Ther, 2016; 18: 772–783.
8.
TronconeA, BonfantiR, IafuscoD, et al.Evaluating the experience of children with type 1 diabetes and their parents taking part in an artificial pancreas clinical trial over multiple days in a diabetes camp setting. Diabetes Care, 2016; 39: 2158–2164.
9.
HaidarA, LegaultL, Matteau-PelletierL, et al.Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial. Lancet Diabetes Endocrinol, 2015; 3: 595–604.
10.
El-KhatibFH, BalliroC, HillardMA, et al.Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial. Lancet, 2016; 389: 369–380.
11.
KudvaYC, CarterRE, CobelliC, BasuR, BasuA. Closed-loop artificial pancreas systems: physiological input to enhance next-generation devices. Diabetes Care, 2014; 37: 1184–1190.
12.
WeismanA, BaiJ-W, CardinezM, KramerCK, PerkinsBA. Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials. Lancet Diabetes Endocrinol, 2017; 5: 501–512.
